Connection
Michael Verneris to Heart Diseases
This is a "connection" page, showing publications Michael Verneris has written about Heart Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.224 |
|
|
|
-
Burke MJ, Trotz B, Luo X, Weisdorf DJ, Baker KS, Wagner JE, Verneris MR. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients. Bone Marrow Transplant. 2009 Aug; 44(3):169-74.
Score: 0.224